OrbusNeich says it began enrolling patients in the Harmonee clinical trial of its Combo dual-therapy coronary stent, ahead of a planned bid for Japanese Shonin approval.
OrbusNeich Medical said it launched a clinical trial in the U.S. and Japan for its Combo dual-therapy coronary stent as it gears up to apply for Shonin approval in Japan.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oJ9YPL
Cap comentari:
Publica un comentari a l'entrada